PROCEPT BioRobotics Corp Income Statement
PRCT / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
PROCEPT BioRobotics Corp reported $308M in revenue and $96M in net loss for FY2025. Revenue has grown at a 109.0% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $308.1M | $224.5M | $136.2M | $75.0M | $34.5M | $7.7M |
| Cost of Revenue | $111.8M | $87.4M | $65.1M | $37.9M | $18.6M | $9.0M |
| Gross Profit | $196.2M | $137.1M | $71.0M | $37.1M | $15.9M | -$1.3M |
| SG&A Expense | $228.8M | $171.4M | $131.8M | $88.8M | $51.0M | $30.3M |
| R&D Expense | $71.3M | $62.3M | $48.4M | $29.0M | $19.0M | $16.3M |
| Operating Income | -$103.9M | -$96.6M | -$109.2M | -$80.7M | -$54.2M | -$47.8M |
| Interest Expense | - | - | $4.0M | $5.2M | $5.8M | $5.3M |
| Income Tax | $190.0K | $368.0K | $80.0K | $0 | $0 | $0 |
| Net Income | -$95.6M | -$91.4M | -$105.9M | -$87.2M | -$59.9M | -$53.0M |
| EPS (Basic) | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
| EPS (Diluted) | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
| Shares Outstanding | 55.5M | 52.1M | 47.3M | 44.4M | 16.5M | 3.7M |
| Gross Margin | 63.7% | 61.1% | 52.2% | 49.4% | 46.0% | -16.3% |
| Operating Margin | -33.7% | -43.0% | -80.2% | - | - | - |
| Profit Margin | -31.0% | -40.7% | -77.8% | -116.2% | -173.6% | - |